54gene Revenue and Competitors
Estimated Revenue & Valuation
- 54gene's estimated annual revenue is currently $48.2M per year.
- 54gene's estimated revenue per employee is $193,750
- 54gene's total funding is $44.7M.
Employee Data
- 54gene has 249 Employees.
- 54gene grew their employee count by -48% last year.
54gene's People
| Name | Title | Email/Phone |
|---|
54gene Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is 54gene?
54gene was founded in 2019 by Dr. Abasi Ene-Obong to address the significant gap in the global genomics market; Nearly 90% of genetic material used in pharmaceutical research is Caucasian. Only 2% is African, despite the fact that Africans and people of African ancestry are more genetically diverse than all other world populations combined. As a result, pharmaceutical research and development is lacking the diverse data that may hold the key to medical discoveries and new healthcare solutions.
keywords:N/A
$44.7M
Total Funding
249
Number of Employees
$48.2M
Revenue (est)
-48%
Employee Growth %
N/A
Valuation
N/A
Accelerator
54gene News
54gene, a Washington, DC-based health technology company, raised $25M in Series B funding. The round, which brought total funding raised to date to more than $45M since being founded in 2019, was led by Cathay AfricInvest Innovation Fund with participation from Adjuvant Capital, KdT Ventures, P ...
WASHINGTON, Sept. 16, 2021 /PRNewswire/ -- 54gene, the health technology company advancing African genomics research for improved global health outcomes, has secured $25M in a Series B round, led by Cathay AfricInvest Innovation Fund. The round also included participation from Adjuvant Capital ...
54gene, a Nigerian genomics research, services, and development company, closed a Series A round of $15M. The round was led by Adjuvant Capital, a life sciences fund backed by the International Finance Corporation, Novartis, and the Bill & Melinda Gates Foundation, with participation from Raba ...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15M | 249 | -11% | N/A |
#2 | $60.3M | 249 | 13% | N/A |
#3 | $35M | 249 | 12% | N/A |
#4 | $27.9M | 249 | 5% | N/A |
#5 | $79.4M | 249 | 21% | N/A |